Evolution of acute coronary syndrome with normal coronary arteries and normal cardiac magnetic resonance imaging  by Chopard, Romain et al.
Archives of Cardiovascular Disease (2011) 104, 509—517
CLINICAL RESEARCH
Evolution of acute coronary syndrome with normal
coronary arteries and normal cardiac magnetic
resonance imaging
Évolution des syndromes coronaires à coronaires angiographiquement normales
et IRM cardiaque normale
Romain Choparda,∗, Jerome Jehlb, Johanna Dutheil a,
Vincent Descotes Genona, Marie-France Serondea,
Bruno Kastlerb, Francois Schielea, Nicolas Meneveaua
a Department of Cardiology, University Hospital Jean-Minjoz, University of Franche-Comte,
boulevard Fleming, 25000 Besanc¸on, France
b Department of Radiology, University Hospital Jean Minjoz, University of Franche-Comte,
Besanc¸on, France
Received 15 March 2011; received in revised form 12 May 2011; accepted 17 May 2011
Available online 1 September 2011
KEYWORDS
Acute coronary
syndrome;
Tako-tsubo
cardiomyopathy;
Myocarditis;
Cardiac magnetic
Summary
Background.— Acute coronary syndrome (ACS) with normal coronary angiography is a frequent
clinical situation with an uncertain prognosis. Cardiac magnetic resonance imaging (CMRI) is a
powerful tool for differential diagnosis between myocardial infarction (MI), acute myocarditis
and Tako-tsubo cardiomyopathy (TTC). Data are sparse regarding the evolution of patients
presenting an ACS with normal coronary arteries and normal CMRI.
Aims.— To evaluate the evolution of patients presenting an ACS with normal coronary arteriesresonance imaging;
Evolution
and normal CMRI, with a 1-year follow-up.
Methods.— Eighty-seven consecutive patients (mean age, 53 years; 40.2% men) presenting an
ACS with troponin elevation and normal coronary arteries by angiography were prospectively
included. All patients underwent CMRI at 3-Tesla. Adverse events were recorded with 1-year
follow-up.
Abbreviations: ACS, acute coronary syndrome; AMI, acute myocardial infarction; CMRI, cardiac magnetic resonance imaging; cTnI,
cardiac troponin I; ECG, electrocardiogram; LGE, late gadolinium enhancement; LV, left ventricular; LVEDI, left ventricular end-diastolic
volume index; LVEF, left ventricular ejection fraction; LVESI, left ventricular end-systolic volume index; PE, pulmonary embolism; TTC,
Tako-tsubo cardiomyopathy; TTE, transthoracic echocardiography.
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Results.— A likely aetiology for the acute clinical presentation was established by CMRI in 63.2%
of patients (22.7% MI, 26.4% acute myocarditis, 11.5% TTC). During follow-up, one patient in
the MI group had a stroke (1.2%). In the myocarditis group, there was one initial cardiogenic
shock, one episode of congestive heart failure (1.2%) and nine patients had recurrent chest pain
without troponin elevation (10.3%). Two TTC group patients initially presented with cardiogenic
shock (2.4%); there were no other adverse events in this group during follow-up. In the remaining
36.7% patients, no clear diagnosis could be identiﬁed by CMRI, and no adverse events occurred
during follow-up.
Conclusion.— CMRI is a useful tool for the management of ACS presenting with normal coronary
angiography, as it helps to ascertain the diagnosis and adapt treatment in a large proportion
of cases. Nonetheless, patients with no abnormalities identiﬁed by CMRI have an excellent
evolution.
© 2011 Published by Elsevier Masson SAS.
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Résumé
Objectifs.— Le syndrome coronaire aigu (SCA) avec des artères coronaires angiographiquement
normales est une situation clinique fréquente mais avec un pronostic incertain. L’IRM cardiaque
est un examen performant pour le diagnostic différentiel entre l’infarctus du myocarde (IDM),
la myocardite aiguë et le syndrome de Tako-tsubo. Peu de données sont disponibles concernant
l’évolution des SCA à coronaires normales et IRM cardiaque normale.
Méthode.— Quatre-vingt sept patients (âge moyen : 53 ans, 40,2 % d’hommes) présentant un
SCA avec augmentation de la troponine et des artères angiographiquement normales ont été
prospectivement inclus. Tous les patients ont bénéﬁcié d’une IRM cardiaque à 3-Tesla et les
évènements indésirables étaient recensés avec un suivi d’un ans.
Résultats.— Un diagnostic étiologique a été établi par l’IRM chez 63,2 % des patients (22,7 %
avaient un IDM, 26,4 % une myocardite aiguë, 11,5 % un Tako-tsubo). Au cours du suivi, un patient
du groupe IDM a présenté un accident vasculaire cérébral (1,2 %). Dans le groupe myocardite
aiguë, il a été retrouvé un état de choc cardiogénique initial, un épisode de décompensation
cardiaque et neuf patients ont présenté des récidives douloureuses thoraciques sans augmen-
tation de la troponine (10,3 %). Deux patients du groupe Tako-tsubo présentaient initialement
un état de choc cardiogénique, puis il n’a été noté aucun autre évènement indésirable au cours
du suivi dans ce groupe. Finalement, pour les 36,7 % des patients restant, chez qui l’IRM ne per-
mettait pas de poser un diagnostic ﬁnal, aucun évènement indésirable n’ait survenu au cours
du suivi d’un ans.
Conclusion.— L’IRM cardiaque est un examen performant pour la prise en charge des SCA à
coronaires angiographiquement normales qui permet d’afﬁrmer un diagnostic et ainsi d’adapter
les thérapeutiques dans une large proportion de cas. Par ailleurs, les patients qui ne présentent
pas d’anomalie à l’IRM on une excellente évolution.
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cute coronary syndromes (ACS) are one of the leading
auses of death and morbidity in industrialized countries [1].
ypical presentation includes acute chest pain and cardiac
roponin I (cTnI) elevation, possibly associated with elec-
rocardiogram (ECG) abnormalities. Subsequent coronary
ngiography usually reveals ﬂow-limiting epicardial stenoses
2]. However, coronary angiography can be normal in 1 to
2% of cases, depending on the deﬁnition of ‘‘normal’’ coro-
ary arteries [3—5].
Differential diagnosis can thus be challenging and
ossible diagnoses include acute myocardial infarction
AMI), generally limited to the subendocardial territory
6], and two non-ischemic myocardial diseases, namely
cute myocarditis [7] and transient apical ballooning syn-
rome, also known as Tako-tsubo cardiomyopathy (TTC)
8].
a
[
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Cardiac magnetic resonance imaging (CMRI) is a highly
ensitive noninvasive technique for detecting myocardial
amage in ischemic [9] and non-ischemic cardiac disease,
ncluding acute myocarditis [10] and TTC [11].
Management strategy and follow-up can be thus adapted
econdarily, further to the results of CMRI, with the initiation
f secondary prevention treatment, including antiplatelet
herapy, when CMRI conﬁrms a diagnosis of AMI [2]. How-
ver, Assomull et al. demonstrated that CMRI can identify
he basis for cTnI elevation in only 65% of patients pre-
enting ACS symptoms and unobstructed coronary arteries
12]. Moreover, the evolution of this clinical situation, usu-
lly reported in the past as uniformly benign [4,13], might
n fact be less favourable, with one recent study reporting
signiﬁcantly high rate of death and major adverse events
5].
In this context, the aim of this study was to evaluate
he evolution of patients presenting with ACS and normal
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coronary arteries and normal CMRI, with a follow-up of 1
year. For CMRI evaluation, the latest technology available in
clinical practice was used with a high ﬁeld of Tesla.
Methods
Study population
Patients with clinical suspicion of ACS (ST-segment elevation
myocardial infarction or non-ST-segment elevation ACS) and
with strictly normal coronary arteries on coronary angiog-
raphy were prospectively recruited in this observational
study. Inclusion criteria were deﬁned as: the associa-
tion of new onset chest pain present at rest, lasting for
longer than 30minutes; elevated cTnI; and normal coronary
angiography, performed no later than 72 hours after admis-
sion and reviewed by two experienced observers. Other
initial investigations and searches for alternative causes
of cTnI elevation, systematically including transthoracic
echocardiography (TTE), had proved diagnostically incon-
clusive. Intracoronary methylergonovine testing was also
systematically performed during angiography to exclude
coronary vasospasm. Exclusion criteria included prior history
of cardiovascular disease, previous coronary intervention,
high Framingham risk score (10-year risk greater than
10%) and standard CMRI contraindications. Patients pre-
senting with cardiac rhythm disorders, such as atrial
ﬁbrillation, which could explain cTnI elevation, were also
excluded.
Data collected included baseline characteristics, medica-
tion at admission and ECG abnormalities using the Minnesota
code [14]. Daily blood samples were obtained to assess
peak cTnI, lipid proﬁle, inﬂammatory markers including
C-reactive protein, B-type natriuretic peptide, glycaemia
and creatinine concentration to evaluate glomerular ﬁltra-
tion rate. The threshold used in the core laboratory to
deﬁne a positive cTnI was 0.15 ng/mL and cTnI assessment
was performed every 6 hours until peak concentrations were
reached. Framingham [15] and Global Registry of Acute
Coronary Events (GRACE) [16] risk scores were calculated for
each patient to evaluate long- and short-term risk of death.
Myocardial tissue biopsy was not envisaged to establish a
diagnosis.
All patients initially received standard medical therapy
for ACS, including antiplatelet therapy, statins, angiotensin-
converting enzyme inhibitors and beta-blockers, according
to international guidelines [2,17]. Treatment strategy
was subsequently adjusted according to the results of
CMRI. In case of myocarditis, anti-inﬂammatory ther-
apy was initiated if chest pain indicative of associated
pericardial reaction persisted. For TTC, treatment was
initiated at the physician’s discretion, combining an
inhibitor of the renin-angiotensin system with beta-
blocker therapy. If CMRI was normal, all therapy was
stopped.
Cardiac magnetic resonance imagingCMRI scans were performed during hospital stay or within
3 weeks of initial presentation and repeated at 3 months
in case of suspected TTC to evaluate improvement in left
m
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entricular (LV) function. CMRI studies were conducted at
.0 ﬁeld strength (General Electric Healthcare Company,
igna HD, Milwaukee, WI, USA) with a standard 40mT/m
radient, using an eight-element phased array surface coil.
eft ventricular function was assessed by ECG-gated cine
teady-state free precession (SSFP) breath-hold sequences
n the two-chamber and four-chamber views as well as in
he short cardiac axis from base to apex (30 phases per car-
iac cycle; repetition time, 3.5ms; echo time, 1.2ms; ﬂip
ngle, 45◦; typical voxel size, 1.92× 1.25× 8.0mm) [18].
2-weighted images (triple inversion recovery; TE, 60ms;
R, 2×R-R interval; TI, 170ms; slice thickness, 7mm; ﬂip
ngle, 180◦; pixel size, 2.3× 1.3mm) were acquired in
he short-axis plane. First-pass perfusion imaging was per-
ormed using a T1-weighted fast gradient echo sequence
FGRE TR/TE = 3.5ms/1.5ms) with a notched saturation
ulse, after the injection of a bolus of gadolinium (Dota-
d; Guerbet, Roissy, France) in a brachial vein at a single
ose of 0.2mL/kg (0.1mmol/kg). The ﬁeld of view was
00mm and the matrix size was 256× 224 interpolated to
56× 256. The heart was imaged in the short-axis plane
ith four to six slices, 8mm thick with a gap of 1mm. One
mage per slice was acquired every two cardiac cycles, lead-
ng to a temporal resolution of 2 R-R per imaging plane.
orty frames were obtained from each imaged plane within
0 R-R. For late gadolinium enhancement (LGE) imaging at
and 15minutes, a breath-hold ECG-gated T1-weighted
equence was used (TE =MinFull; ﬁeld of view, 440mm; TI
ptimised to obtain optimal myocardial nulling; matrix size,
56× 224 interpolated to 256× 256; slice thickness, 8mm;
ap, 1mm) [19]. The number and position of the slices
ere the same as used for the perfusion ﬁrst-pass imag-
ng.
Ofﬂine image analysis was performed on a dedicated
orkstation (General Electric Healthcare Company, Milwau-
ee, WI, USA). The endocardial border was drawn manually
n each dynamic image. Left ventricular ejection fraction
LVEF), end-diastolic and end-systolic volume indexes (LVEDI
nd LVESI, respectively) and LV mass index were calculated
rom the short-axis view [20]. Qualitative interpretation of
MRI scans was performed by two reviewers by consensus.
eaders were blinded to the clinical situation. The portion
f the heart exhibiting late enhancement and/or T2 high
ignal intensity was classiﬁed according to the segmenta-
ion established by the American Heart Association, which
ivides the left ventricle into 17 segments [21]. LGE images
nd corresponding T2-weighted images were assessed for
ubendocardial signal abnormalities in the distribution of
coronary artery, compatible with AMI [9]. Diagnosis of
cute myocarditis was made according to criteria previously
escribed by Friederich et al. with detection of oedema
n T2-weighted images, hyperaemia and capillary leakage
n myocardial early (3minutes) gadolinium enhancement
equences and necrosis or ﬁbrosis in LGE images detected in
he midwall/subepicardial regions [10]. TTC was suspected
n initial CMRI if there were no signs of delayed enhance-
ent, T2 signal intensity and LV dysfunction, especially with
id/apical ballooning; TTC was conﬁrmed by complete nor-
alization of LVEF on the follow-up CMRI at 3 months. Scans
ith volumes and function within the normal range, with no
GE and T2 signal intensity abnormalities were considered
ormal by CMRI.
5 R. Chopard et al.
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Table 1 Baseline characteristics.
Characteristics Value (n = 87)
Age (years) 53± 18.5
Men 35 (40.2)
History of smoking 35 (40.2)
Hypertension 28 (32.2)
Dyslipidaemia 30 (34.5)
Diabetes mellitus 8 (9.2)
Obesity (body mass index > 30) 10 (11.5)
Family history of ischemic heart
disease
30 (34.5)
Peak cardiac troponin I 9.3± 10.91
Peak C-reactive protein (mg/L) 12.3± 7.6
Leukocytes (g/L) 8.5± 3.75
Fibrinogen (g/L) 4.0± 1.41
Glomerular ﬁltration rate
(mL/minute)
87.7± 30.4
Glycaemia (g/L) 1.09± 0.66
Framingham risk score 6.82± 7.46
GRACE risk score 104.67± 27.03
Medications on admission
Antiplatelet therapy 2 (2.3)
Statins 27 (31)
Angiotensin-converting
enzyme inhibitor/angiotensin
II blocker
16 (18.4)
Beta-blocker 8 (9.2)
Patient thrombolysed 0
Data are mean± standard deviation or number (%).
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utcomes
he subsequent progress of patients was assessed by tele-
hone contact at 1, 3, 6 and 12 months. In case of clinical
vents, these were conﬁrmed by hospital records or contact
ith the general practitioner. Clinical endpoints evalu-
ted were death, recurrent ACS, congestive heart failure,
troke and recurrence of chest pain without cTnI eleva-
ion.
tatistical analysis
ontinuous data are expressed as mean± standard devia-
ion. Baseline characteristics were compared between the
iagnostic CMRI group and the group in which CMRI was
udged to be normal, using an independent sample t test
nd the Chi2 test for categorical variables, as appropri-
te. All tests were two sided. A P value of less 0.05
as considered statistically signiﬁcant. All statistical anal-
ses were performed using MedCalc© (Mariakerke, Ghent,
elgium).
esults
aseline characteristics
mong a total of 1687 patients admitted to our institution for
CS between January 2008 and September 2009, 87 (5.1%)
ad a normal coronary angiogram and met the inclusion cri-
eria. Baseline characteristics are summarized in Table 1.
he mean age was 53± 18.5 years and 59.8% were women
n = 52). No patient had pre-existing renal impairment, prior
xposure to cardiotoxic drugs or prior chemotherapy. At the
ime of cTnI evaluation, no patient had symptoms suggestive
f alternative cause of cTnI elevation, such as septicaemia,
troke, renal insufﬁciency, pulmonary embolism (PE) or aor-
ic dissection. Eight patients (9.2%) described psychological
tress before clinical presentation. The prevalence of car-
iovascular risk factors and primary prevention therapy
as moderate. No patient underwent thrombolytic therapy.
ixty-nine (75.8%) patients had an abnormal ECG on pre-
entation. ST-segment depression was the most commonly
etected abnormality (59.4%), followed by T wave changes
26.5%). One patient presented left bundle branch block
1.1%) and none had supraventricular or ventricular tachy-
ardia. No patient with ST-segment elevation was eligible
or inclusion. No criteria of right ventricle overload indica-
ive of PE with cTnI elevation were found in the initial TTE
nd 32 patients (36.8%) underwent further investigation by
T pulmonary angiography (n = 22) and ventilation perfusion
sotope scans, which did not show evidence of embolism in
ny patient.
ardiac magnetic resonance imaging
he median time from presentation of ACS to CMRI was
0.3 days (range 5—22 days). One scan was repeated
ecause the quality was suboptimal. Thus, complete CMRI
mages were available for all patients. CMRI dimensions
ere 86.7± 24.7mL/m2 for LVEDI and 41.7± 14.5mL/m2 for
VESI. LV mass index was 86.4± 18.6 g/m2 and LVEF was
d
v
m5.1± 13.6%. The diagnoses determined by CMRI are sum-
arized in Table 2. CMRI provided a diagnosis in 55 patients
63.2%).
CMRI revealed subendocardial or transmural T2 high
ignal area and corresponding LGE in the distribution of
oronary artery compatible with AMI in 22 patients (22.7%)
Fig. 1). CMRI suggestive of AMI was located in the ante-
ior wall in two cases (9.1%), in the lateral wall in eight
ases (36.6%) and in the inferior wall in 12 cases (54.4%). LGE
as transmural for four patients. A diagnosis of myocardi-
is was established in 23 patients (26.4%) by gadolinium
nhancement and T2-weighted sequences (Fig. 1). The most
ommon midwall/epicardial high signal intensity areas were
ound in the lateral wall (15 patients; 65.2%). All patients
ad evidence of acute inﬂammation with increased mid-
all/epicardial T2 signal intensity.
A diagnosis of TTC was conﬁrmed in ten patients
11.5%) with normalization of LV systolic function at 3
onths (Fig. 2). In three patients (3.8%), LVEF at 3
onths was estimated by TTE as CMRI was not available.
e observed high signal intensity areas with T2-weighted
maging being suggestive of myocardial oedema in four
atients.In the 32 remaining patients (36.7%), there was no
etectable myocardial necrosis or inﬂammation and left
entricular function was normal and no new diagnosis was
ade.
Evolution of ACS with normal coronary arteries and normal cardiac MRI. 513
Table 2 Cardiac magnetic resonance imaging diagnosis.
CMRI diagnosis Assomull
et al. [12]
n (%)
Current study
n (%)
1-year follow-up adverse
events, current study
Myocardial infarction 7 (11.6) 22 (22.7) One stroke (1.2%)
Myocarditis 30 (50.0) 23 (26.4) One cardiogenic shock (1.2%);
one congestive heart failure
(1.2%); nine recurrences of
chest pains (10.3%)
TTC 1 (1.7) 10 (11.5) Two cardiogenic shocks (2.4%)
Normal CMRI 21 (35.0) 32 (36.7) None
CMRI: cardiac magnetic resonance imaging; TTC: Tako-tsubo cardiomyopathy.
a
v
(Normal versus abnormal cardiac magnetic
resonance imagingThere was no signiﬁcant difference in baseline charac-
teristics such as age, sex, cardiovascular risk factors or
risk scores between the groups with and without CMRI
w
f
g
Figure 1. Cardiac magnetic resonance with late gadolinium enhancem
infarction (C and D). Typical pattern of acute myocarditis with patchy mid
short-axis (A) and four-chamber (B) views. Transmural delayed enhancem
black regions within the white areas of late enhancement corresponding
four-chamber (D) views.bnormalities. As regards biological markers, only cTnI ele-
ation was signiﬁcantly lower in the normal CMRI group
3.48± 4.3 vs 11.86± 11.99g/L, P = 0.0028). ECG ﬁndings
ere also similar in both groups. CMRI LV dimensions and
unction as well as time to CMRI did not differ between
roups (Table 3).
ent imaging in acute myocarditis (A and B) and in acute myocardial
-wall delayed enhancements localized in the lateral wall (arrows);
ent in the inferior wall suggestive of myocardial infarction (arrows);
to persistent microvascular obstruction (arrows); short-axis (C) and
514 R. Chopard et al.
Figure 2. Serial late gadolinium enhancement cardiac magnetic resonance imaging in Tako-tsubo cardiomyopathy. Images acquired
at baseline scanning demonstrate apical hypokinesia (A and B) in the absence of late gadolinium enhancement (C). A repeat scan 3
months later shows complete normalization of left ventricular function (D and E) with no late gadolinium enhancement detectable
(
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ollow-up
ollow-up information was available for all patients. No
ew or alternative diagnosis was made for any patient
uring follow-up. One-year follow-up adverse events are
ummarized in Table 2. No death or recurrent ACS was
bserved during follow-up. Three patients (3.5%) had car-
iogenic shock at admission. For one patient, CMRI provided
t
f
p
Table 3 Cardiac magnetic resonance imaging variables in nor
CMRI variable Normal(n = 32)
LVEDI (mL/m2) 85.5± 16.3
LVESI (mL/m2) 39.5± 14.5
LV mass index (g/m2) 79± 23.7
LVEF (%) 65.7± 10.7
Interval to scan (days) 7 (1—18)
Data are mean± standard deviation or median (range). CMRI: cardia
ventricular end-diastolic volume index; LVEF: left ventricular ejectionhe diagnosis of acute myocarditis and for the two oth-
rs, the diagnosis of TTC was made. Two (2.4%) patients
ere rehospitalized during follow-up: one for stroke (1.2%),
n whom AMI had been diagnosed on initial CMRI, and one
or congestive heart failure at 3 months, after an ini-
ial diagnosis of myocarditis with alteration of LV systolic
unction. Nine patients (10.3%) from the myocarditis group
resented recurrent chest pain during follow-up, without
mal and abnormal groups.
Abnormal(n = 55) P
89.6± 18.4 0.35
44.6± 12.5 0.22
84.7± 14.7 0.19
58.4± 9.2 0.16
9 (4—22) 0.84
c magnetic resonance imaging; LV: left ventricular; LVEDI: left
fraction; LVESI: left ventricular end-systolic volume index.
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rehospitalization or cTnI elevation. Among the patients with
normal CMRI (n = 32), no adverse events were observed dur-
ing follow-up.
Discussion
Elevated cTnI concentration reﬂects with good sensitivity
and speciﬁcity the existence of myocardial necrosis [22].
Nevertheless, there are a number of other causes of ele-
vated cTnI in the absence of coronary artery disease, as
recently summarized by Jeremias et al. [23], including car-
diac arrhythmia and non-cardiac causes such as PE, sepsis
or systemic inﬂammatory response syndrome, renal fail-
ure and neurological disorders. In our study, we excluded
patients with any non-cardiac diseases that could interfere
with cTnI concentration. In particular, no patient presented
criteria of right ventricular overload evocative of PE, with
cTnI elevation at initial TTE. Indeed, we performed further
investigations in 36.8% of patients to exclude a diagnosis of
PE. However, there is always the possibility that an episode
of rapid cardiac rhythm disorder, undetected at admission
or during follow-up, may have caused the elevation of cTnI.
Furthermore, we retained only three possible aetiologies
that could explain a clinical presentation associating acute
chest pain, elevated cTnI and normal coronary angiography,
namely AMI [24], acute myocarditis [7] and TTC [8].
AMI with normal coronary angiography is a common
clinical situation and several different pathophysiological
mechanisms have been proposed. Firstly, coronary angiog-
raphy suffers limitations as a diagnostic technique due to its
spatial resolution, which is limited to 200m, and the fact
that only arterial patency can be judged, without providing
much information on the arterial wall. However, most ACSs
derive from atheroma causing less than 50% diameter steno-
sis, which occurs more frequently than tighter stenoses [25].
Vulnerable plaques that give rise to ACS present a positive
remodelling effect, with expansion towards the outer layer
of the vessel rather than towards the lumen [26]. In AMI
with normal coronary arteries, rupture or erosion of a vul-
nerable plaque can occur, causing transitory occlusion that
resolves spontaneously, without leaving any residual visible
intracoronary lesion [27]. The simultaneous use of coronary
angiography and invasive catheter-based techniques, such
as intravascular ultrasound or optical coherence tomogra-
phy, could make it possible to establish an ischemic cause
of ACS with normal coronary arteries, by identifying, for
example, thrombus or vulnerable plaque with rupture of
a thin-cap ﬁbroatheroma [28,29]. However, these imaging
techniques do not investigate distal vessels or small-calibre
side branches. Furthermore, other mechanisms can also,
albeit more rarely, give rise either separately or in com-
bination, to distal embolisation [30], coronary vasospasm
[31], inﬂammation [32] or coronary dissection [33]. It is now
well established that acute myocarditis can mimic ACS [7],
with elevation of cTnI in up to 49% of cases [34]. The most
common aetiology of myocardial inﬂammation is viral infec-
tion, mainly involving adenoviruses and enteroviruses [35].
The clinical presentation of TTC is also practically indis-
tinguishable from that of ACS, but with normal coronary
angiography and initial transient LV dysfunction. The role of
catecholamine-induced myocardial stunning or multivessel
a
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picardial or microvascular spasm have been previously
een suggested as possible causes of TTC [36].
Thus, establishing an accurate diagnosis in the presence
f ACS with normal coronary arteries is of paramount impor-
ant, particularly so that management can be appropriately
djusted. Patients with conﬁrmed AMI need long-term
ollow-up and secondary prevention treatment [2]. CMRI is
ncreasingly used to diagnose ischemic heart disease and can
rovide non-invasive evaluation of myocardial wall motion,
lobal function, perfusion and viability [9]. T2-weighted
nd LGE sequences are currently considered as the gold
tandard for in vivo detection of scarring associated with
yocardial infarction [37], as well as for identifying other
on-ischemic conditions, including myocarditis [10]. In case
f TTC, CMRI can identify transient LV dysfunction on cine
equences, without any visible myocardial injury after injec-
ion of gadolinium [38].
CMRI is thus a useful noninvasive imaging tool that makes
t possible to identify aetiology of ACS with normal coronary
rteries in up to 65% of cases, as reported by Assomull et al.
12]. In our study, a diagnosis was established in 63.2% of
ases, which is very similar to the rate observed in previous
eports, as shown in Table 2. In our study, CMRI brought to
ight mainly myocarditis (26.4%), AMI (22.7%) and, to a lesser
xtent, TTC (11.7%). Most importantly, CMRI was normal and
ed to no deﬁnitive diagnosis being established in almost one
hird of patients, as in the study by Assomull et al., even
ith the use of high ﬁeld 3-Tesla CMRI, which theoretically
ncreases spatial resolution [39]. To the best of our knowl-
dge, the current study was the ﬁrst to assess myocardial
njury in case of ACS with normal coronary angiography by
sing this new technology, but it does not appear to improve
iagnostic accuracy. In our study, as reported elsewhere,
he cTnI concentration was signiﬁcantly lower in the group
f patients with normal CMRI compared with in those with
athological CMRI (3.48± 4.3g/L vs 11.86± 11.99g/L,
= 0.0028 in the current study). We hypothesize that in the
roup with normal CMRI, the myocardial injury, known to be
orrelated with cTnI [40], was probably too limited to be
etected by CMRI at 1.5- or 3-Tesla, due to the limited spa-
ial resolution with partial volume effects. It is noteworthy
hat a delayed contrast-enhanced cardiac computed tomog-
aphy scan is also able to provide detailed information on
yocardial tissue characteristics associated with myocar-
ial infarction and myocarditis, with less contrast resolution
han CMRI [41], and could be used in the clinical situation
f ACS with normal coronary arteries.
Until recently, the prognosis of patients with ACS and
ormal coronary arteries was considered to be excellent,
n the basis of several small studies showing a low recur-
ence rate of ACS and a high 10-year survival rate [4,5].
owever, a more recent study that included 9796 patients
ith ACS undergoing coronary angiography showed a less
avourable outcome [5]. In this study, patients with strictly
ormal angiograms (n = 273) were found to have a mortal-
ty of 1.8% at 30 days and of 4.0% at 1 year. However, to
ate, no study has used CMRI to distinguish between the
ossible aetiologies of ACS in this population or to evalu-
te prognosis. In general, patients with myocarditis seem to
ave favourable evolution and in most cases, early normal-
zation of echocardiography and ECG variables, laboratory
alues and functional status is observed, although up to 13%
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f patients reported atypical non-limited chest discomfort
42]. In TTC, the evolution is, again, generally favourable,
ith a 4-year survival that was not different from that of an
ge- and sex-matched population in one angiographic study
43]. Eitel et al. also failed to observe any major adverse
vents after a median follow-up of 3.3 months in patients
ith a diagnosis of TTC established by MRI [44]. The greatest
isk exists during the initial phase, when complications such
s ventricular arrhythmia or cardiogenic shock can be life
hreatening [43]. In our study, we observed 5.7% of major
dverse cardiac events, with one stroke in the AMI group,
ne episode of congestive heart failure and three initial car-
iogenic shocks but no death during the 1 year of follow-up.
urthermore, there was no adverse event in the group of
atients who had normal coronary angiography and normal
MRI. Thus, it would appear that evolution in this population
ould be excellent and therapeutic strategy and follow-up
ould be secondarily adapted. A further study with a larger
ample size and longer follow-up is necessary to provide
onﬁrmation of the positive tendency observed in our study.
onclusion
MRI is a useful tool for the management of ACS presenting
ith normal coronary angiography, as it helps to ascertain
iagnosis and adapt treatment in a large proportion of cases.
onetheless, patients with no abnormalities identiﬁed by
MRI have an excellent evolution.
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